Literature DB >> 34317939

Outcomes of novel surgical procedures for graft size mismatch in living-donor lobar lung transplantation.

Daisuke Nakajima1, Satona Tanaka1, Akihiro Ohsumi1, Hiroshi Date1.   

Abstract

Entities:  

Year:  2020        PMID: 34317939      PMCID: PMC8303078          DOI: 10.1016/j.xjtc.2020.06.037

Source DB:  PubMed          Journal:  JTCVS Tech        ISSN: 2666-2507


× No keyword cloud information.
Novel LDLLT provided similar survival to standard procedure. Novel LDLLT such as native upper lobe–sparing, right-to-left inverted, and single-lobe transplants overcame graft size mismatch and showed good post-transplant pulmonary function and survival. See Commentaries on pages 392, 394, 396, and 398. Various living-donor lobar lung transplantations (LDLLTs) have been developed to resolve the serious issue of graft size mismatch. The procedures of “native upper lobe–sparing transplant” and “right-to-left inverted transplant” have been employed as strategies for managing undersized grafts, and single-lobe transplant has been used to manage oversized grafts. The purpose of this study was to compare the outcomes of newly developed transplant techniques with those of the standard LDLLT approach.

Methods

Between June 2008 and May 2018, we performed 47 standard LDLLT (standard group), 22 native upper lobe–sparing transplants and/or right-to-left inverted transplants for undersized grafts (sparing/inverted group), and 11 single-lobe transplants for oversized grafts (single group). Each transplant case was carefully reviewed and approved by the Lung Transplant Evaluation Committee at Kyoto University Hospital. The study protocol was approved by the institutional review board of Kyoto University Hospital (R2389), and written informed consent was obtained from each participant. Each transplant procedure and inclusion criteria have been previously reported.1, 2, 3 In standard LDLLT, the right and left lower lobes were retrieved from 2 healthy donors and were implanted in a single recipient. In right-to-left inverted LDLLT, the graft bronchus was anastomosed to the recipient left upper lobe bronchus, leaving the recipient left lower bronchial stump closed. The recipient left bronchus was carefully dissected and the bronchial stump was reinforced with the pericardial fat pad to prevent the postoperative bronchopleural fistula. Pulmonary artery anastomosis was performed without twisting behind the bronchial anastomosis (Figure 1). Native upper lobe–sparing (n = 9) and right-to-left inverted transplants (n = 11) were bilateral lung transplants in all cases except one. The native upper lobe–sparing transplant combined with right-to-left inverted transplant was performed in 2 cases. This surgical technique is presented in Video 1. Only right lower lobe was implanted in all single-lobe transplant cases. Among them, 4 patients required delayed chest closure and 1 patient simultaneously underwent left pneumonectomy.
Figure 1

Three-dimensional computed tomography angiography showed no twisting and stenosis of the PA 1 month after ritht-to-left inverted transplantation. PA, Pulmonary artery; LAO, left anterior oblique view; CRA, cranial view.

Three-dimensional computed tomography angiography showed no twisting and stenosis of the PA 1 month after ritht-to-left inverted transplantation. PA, Pulmonary artery; LAO, left anterior oblique view; CRA, cranial view. For functional size matching, the graft forced vital capacity (FVC) was calculated based on the measured donor FVC and the number of resected pulmonary segments. An estimated graft FVC of >45% to 50% of the recipient predicted FVC was usually considered to indicate acceptable size matching of the graft to the LDLLT recipient. For anatomical size matching, 3-dimensional computed tomography (CT) volumetry was performed. The post-transplant outcomes and %FVC and percent forced expiratory volume in 1 second of predicted values were compared among the 3 groups. All data are presented as mean ± standard deviation. Survival was determined by a Kaplan–Meier survival analysis.

Results

The patient characteristics are summarized in Table 1. Native upper lobe–sparing and/or right-to-left inverted transplants were performed mainly for large adult men, whereas most single-lobe transplants were performed in small pediatric patients. Although novel transplant procedures might be complicated in comparison to the standard LDLLT, the total graft ischemic time did not significantly differ among the t3 groups (standard: 118 ± 26 minutes; sparing/inverted: 126 ± 25 minutes; single: 116 ± 32 minutes).
Table 1

Recipient characteristics

Standard (n = 47)Sparing/inverted (n = 22)Single (n = 11)
Age, y40 ± 1941 ± 1412 ± 10
Children <15 y8 (17%)010 (91%)
Sex: male18 (38%)15 (58%)3 (27%)
Height, cm155 ± 13164 ± 9118 ± 12
Indications
 ILD22101
 HSCT1886
 PAH323
 CLAD210
 Others211
Idiopathic or secondary PAH8 (17.0%)4 (18.2%)3 (27.3%)

ILD, Interstitial lung disease; HSCT, pulmonary complication after hematopoietic stem cell transplantation; PAH, pulmonary arterial hypertension; CLAD, chronic lung allograft dysfunction.

Recipient characteristics ILD, Interstitial lung disease; HSCT, pulmonary complication after hematopoietic stem cell transplantation; PAH, pulmonary arterial hypertension; CLAD, chronic lung allograft dysfunction. Early post-transplant outcomes are shown in Table 2. The single group showed significantly lower arterial oxygen tension/inspired oxygen fraction at intensive care unit admission than the standard or sparing/inverted group. Other early outcomes did not significantly differ among the 3 groups. Lung perfusion scintigraphy showed 86.7 ± 2.4% perfusion to the transplanted right lower lobe at 1 year after transplantation in the single group.
Table 2

Early post-transplant outcomes

Standard (n = 47)Sparing/inverted (n = 22)Single (n = 11)
Pao2/Fio2 at ICU admission, mm Hg475 ± 130473 ± 139316 ± 141
ECMO requirement5 (10.6%)02 (18.2%)
Rethoracotomy indications6 (12.8%)hemothorax 5, empyema 12 (9.1%)hemothorax 22 (18.2%)hemothorax 2
Duration of mechanical ventilation, d17 ± 2213 ± 1025 ± 20
Tracheostomy27 (57.4%)16 (72.7%)6 (54.5%)
Bronchial complication4 (8.5%)1 (4.5%)0
30-d mortality1 (2.1%)∗1 (4.5%)†0
In-hospital mortality2 (4.3%)‡1 (4.5%)1 (9.1%)†

Cause of death: ∗thrombosis; †primary graft dysfunction; ‡aspiration pneumonitis. Pa/F, Arterial oxygen tension/inspired oxygen fraction; ICU, intensive care unit; ECMO, extracorporeal membrane oxygenation.

Early post-transplant outcomes Cause of death: ∗thrombosis; †primary graft dysfunction; ‡aspiration pneumonitis. Pa/F, Arterial oxygen tension/inspired oxygen fraction; ICU, intensive care unit; ECMO, extracorporeal membrane oxygenation. In this study, the ratio of the graft volume to the recipient's chest cavity volume was 188 ± 68% in the single group. Although the pretransplant FVC size matching between the donor graft and recipient was significantly lower in the sparing/inverted group (51.8 ± 9.6%, Figure 2, A) than in the standard group (69.1 ± 17.9%) or single group (66.8 ± 18.2%), the pulmonary function at 1 year after transplantation was similar among the 3 groups: %FVC of 59.4 ± 22.1% in the standard group (n = 40), 63.2 ± 18.6% in the sparing/inverted group (n = 19), and 60.5 ± 21.2% in the single group (n = 8) (Figure 2, B) and percent forced expiratory volume in 1 second of 58.7 ± 19.9% in the standard group (n = 41), 61.6 ± 15.0% in the sparing/inverted (n = 19), and 58.2 ± 19.9% in the single group (n = 7) (Figure 2, C). The patients who underwent LDLLT had a favorable exercise capacity at 1 year after transplant, as demonstrated by the 6-minute walking distance (standard [n = 39]: 474 ± 132 m; sparing/inverted [n = 20]: 525 ± 114 m; single [n = 6]: 399 ± 81 m, Figure 2, D).
Figure 2

We performed 47 standard living-donor lobar lung transplants (standard), 22 native upper lobe–sparing transplants and/or right-to-left inverted transplants for undersized grafts (sparing/inverted), and 11 single-lobe transplants for oversized grafts (single). A, The FVC size matching between the graft and recipient was significantly lower in the sparing/inverted group (51.8 ± 9.6%) before transplantation than in the standard group (69.1 ± 17.9%) or single group (66.8 ± 18.2%). The percent FVC of predicted value (B), % FEV1 (C), and 6-minute walking distance (D) were similar among the 3 groups at 1 year after transplantation. FVC, Forced vital capacity; % FEV1, % forced expiratory volume in 1 second.

We performed 47 standard living-donor lobar lung transplants (standard), 22 native upper lobe–sparing transplants and/or right-to-left inverted transplants for undersized grafts (sparing/inverted), and 11 single-lobe transplants for oversized grafts (single). A, The FVC size matching between the graft and recipient was significantly lower in the sparing/inverted group (51.8 ± 9.6%) before transplantation than in the standard group (69.1 ± 17.9%) or single group (66.8 ± 18.2%). The percent FVC of predicted value (B), % FEV1 (C), and 6-minute walking distance (D) were similar among the 3 groups at 1 year after transplantation. FVC, Forced vital capacity; % FEV1, % forced expiratory volume in 1 second. Nobody was lost to follow-up. During the median follow-up period of 5.1 years, 10 patients died in the standard group, 4 patients died in the sparing/inverted group, and 1 patient died in the single group. The overall 5-year survival of LDLLT was 79.0%, and each group showed an excellent 5-year survival (standard: 77.0%; sparing/inverted: 75.4%; single: 90.9%, Figure 3).
Figure 3

The overall 5-year survival was 77.0% after standard living-donor lobar lung transplantation (standard), 75.4% after native upper lobe-sparing transplantation and/or right-to-left inverted transplantation (sparing/inverted), and 90.9% after single-lobe transplantation (single). The dashed lines are the lower and upper 95% confidence interval limits.

The overall 5-year survival was 77.0% after standard living-donor lobar lung transplantation (standard), 75.4% after native upper lobe-sparing transplantation and/or right-to-left inverted transplantation (sparing/inverted), and 90.9% after single-lobe transplantation (single). The dashed lines are the lower and upper 95% confidence interval limits. The donor postoperative outcome is one of the most important things in LDLLT. We performed lobectomy in 148 live donors in this study. Postoperative complications were observed in 22 donors (14.9%), including pneumothorax (n = 8), pleural effusion (n = 7), pleuritis (n = 3), chylothorax (n = 2), hemothorax (n = 1), and empyema (n = 1). Importantly, all donors survived and returned to their previous lifestyle.

Discussion

Native upper lobe–sparing and/or right-to-left inverted techniques have been employed for undersized grafts. In native upper lobe–sparing transplantation, the spared upper lobes can reduce intrathoracic dead space after implantation and provide an adequate chest cavity for the graft so that the undersized lobar graft can be ventilated more efficiently. In right-to-left inverted transplantation, we can implant the 25% larger right lower lobe instead of the left lower lobe into the recipient's left chest cavity. In the present study, the preoperative FVC size matching was significantly increased from 54.0 ± 10.2% in a noninverted setting to 59.7 ± 10.3% in an inverted setting. Therefore, the sparing/inverted group showed an equivalent pulmonary function to the standard group after transplantation despite the significant size discrepancy between the undersized graft and recipient. Functional and anatomical size matching between oversized grafts and small patients is important in single-lobe transplantation. We previously reported that patients who received grafts with an FVC of <60% and a CT volume of >170% developed severe primary graft dysfunction after single-lobe transplantation. Furthermore, when the graft volume is <200% of the recipient chest cavity volume, the graft can be fitted into the small chest cavity of the recipient. In the present study, the mean FVC size matching was 66.8% and the mean CT volumetry size matching was 188% in the single group, which might result in better early post-transplant outcomes and survival than those previously reported values.

Conclusions

Despite its small sample size, this preliminary study includes the broadest experience of LDLLT to describe the utility of novel transplant procedures to deal with graft size mismatch.
  5 in total

1.  Right and left inverted lobar lung transplantation.

Authors:  F Chen; E Miyamoto; M Takemoto; K Minakata; T Yamada; M Sato; A Aoyama; H Date
Journal:  Am J Transplant       Date:  2015-04-02       Impact factor: 8.086

2.  Native upper lobe-sparing living-donor lobar lung transplantation maximizes respiratory function of the donor graft.

Authors:  Akihiro Takahagi; Toyofumi F Chen-Yoshikawa; Masao Saito; Ryo Okabe; Fumiaki Gochi; Hiroya Yamagishi; Masatsugu Hamaji; Hideki Motoyama; Daisuke Nakajima; Akihiro Ohsumi; Akihiro Aoyama; Makoto Sonobe; Hiroshi Date
Journal:  J Heart Lung Transplant       Date:  2018-09-25       Impact factor: 10.247

3.  Outcomes of various transplant procedures (single, sparing, inverted) in living-donor lobar lung transplantation.

Authors:  Hiroshi Date; Akihiro Aoyama; Kyoko Hijiya; Hideki Motoyama; Tomohiro Handa; Hideyuki Kinoshita; Shiro Baba; Toshiyuki Mizota; Kenji Minakata; Toyofumi F Chen-Yoshikawa
Journal:  J Thorac Cardiovasc Surg       Date:  2016-10-31       Impact factor: 5.209

4.  Outcome of living-donor lobar lung transplantation using a single donor.

Authors:  Hiroshi Date; Takeshi Shiraishi; Seiichiro Sugimoto; Tsuyoshi Shoji; Fengshi Chen; Masafumi Hiratsuka; Akihiro Aoyama; Masaaki Sato; Masaomi Yamane; Akinori Iwasaki; Shinichiro Miyoshi; Toru Bando; Takahiro Oto
Journal:  J Thorac Cardiovasc Surg       Date:  2012-06-18       Impact factor: 5.209

5.  Living-donor lobar lung transplantation for various lung diseases.

Authors:  Hiroshi Date; Motoi Aoe; Itaru Nagahiro; Yoshifumi Sano; Akio Andou; Hiromi Matsubara; Keiji Goto; Takeo Tedoriya; Nobuyoshi Shimizu
Journal:  J Thorac Cardiovasc Surg       Date:  2003-08       Impact factor: 5.209

  5 in total
  3 in total

1.  Commentary: When simple living-donor lobar transplantation is just not enough.

Authors:  Konrad Hoetzenecker
Journal:  JTCVS Tech       Date:  2020-08-12

2.  Commentary: Innovative strategies in lobar lung transplantation.

Authors:  Laura L Donahoe; Marc de Perrot
Journal:  JTCVS Tech       Date:  2020-08-15

3.  Commentary: The matchmaker: Novel surgical procedures for graft size mismatch in living-donor lobar lung transplantation.

Authors:  Jules Lin
Journal:  JTCVS Tech       Date:  2020-08-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.